Mangompit, Ailyn .
HRN: 07-87-16 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/01/2024
CO-AMOXICLAV 625MG (TAB)
05/01/2024
05/07/2024
ORAL
1 Tab
2x A Day
NSVD With Perineorrhaphy
Waiting Final Action
Indication: Prophylaxis Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes